Lupus erythematosus induced by medications, ultraviolet radiation, and other exogenous agents: A review, with special focus on the development of subacute cutaneous lupus erythematosus in a genetically predisposed individual

International Journal of Dermatology

Volumn 43, Issue 2, 2004, Pages 87-94

  Shapiro, Michael ^a,b   Sosis, Arthur C ^a,b   Junkins Hopkins, Jacqueline M ^a,b   Werth, Victoria P ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b Advanced Dermatology Associates   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

17ALPHA ESTRADIOL; ANTIHISTAMINIC AGENT; AROMATIC AMINE; AUTOANTIBODY; CALCIUM CHANNEL BLOCKING AGENT; CHLOROQUINE; DAPSONE; ESTROGEN; ETRETIN; FERTILIZER; HEAVY METAL; HYDRAZINE; HYDROCHLOROTHIAZIDE; HYDROXYCHLOROQUINE; INSECTICIDE; INTERCELLULAR ADHESION MOLECULE 1; MEPACRINE; METHOTREXATE; NAPROXEN; ORAL CONTRACEPTIVE AGENT; PESTICIDE; PREDNISONE; RO ANTIBODY; SILICON DIOXIDE; TERBINAFINE; THALIDOMIDE; TOBACCO SMOKE; TRICHLOROETHYLENE; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG;

AGRICULTURE; ALLELE; AUTOIMMUNITY; BACTERIAL INFECTION; CYTOTOXICITY; ENDOTHELIUM CELL; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; HAY; HOMOZYGOTE; HUMAN; IMMUNOGENETICS; KERATINOCYTE; NONHUMAN; PHOTOTOXICITY; PROMOTER REGION; RASH; REVIEW; SKIN LUPUS ERYTHEMATOSUS; SPRING; SYSTEMIC LUPUS ERYTHEMATOSUS; TOBACCO; ULTRAVIOLET RADIATION; VIRUS INFECTION; WATER CONTAMINATION;

ADULT; BIOPSY, NEEDLE; ENVIRONMENTAL EXPOSURE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; INSECTICIDES; LUPUS ERYTHEMATOSUS, CUTANEOUS; MALE; PHARMACEUTICAL PREPARATIONS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TUMOR NECROSIS FACTOR-ALPHA; ULTRAVIOLET RAYS;

EID: 1342290410     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2004.02013.x     Document Type: Review

References (96)

1. Sullivan KE, Wooten C, Schmeckpeper BJ, et al. A promoter polymorphism of tumor necrosis factor alpha associated with systemic lupus erythematosus in African-Americans. Arthritis Rheum 1997; 40: 2207-2211.
2. Siegel M, Lee SL. The epidemiology of systemic lupus erythematosus. Semin Arthritis Rheum 1973; 3: 1-54.
3. Nai-Cheng C. Rheumatic diseases in China. J Rheumatol 1983; 10: 41-44.
4. Frank AO. Apparent predisposition to systemic lupus erythematosus in Chinese patients in West Malaysia. Ann Rheum Dis 1980; 39: 266-269.
5. Serdula MK, Rhoads GG. Frequency of systemic lupus erythematosus in different ethnic groups in Hawaii. Arthritis Rheum 1979; 22: 328-333.
6. Yung RL, Richardson BC. Drug-induced lupus. Rheum Dis Clin North Am 1994; 20: 61-86.
7. Fritzler MJ. Drugs recently associated with lupus syndromes. Lupus 1994; 3: 455-459.
8. Reed BR, Huff JC, Jones SK, et al. Subacute cutaneous lupus erythematosus-like drug eruption due to combination diuretic hydrochlorothiazide and triamterene. J Am Acad Dermatol 1988; 18: 38-42.
9. Crowson AN, Magro CM. Lichenoid and subacute cutaneous lupus erythematosus-like dermatitis associated with antihistamine therapy. J Cutan Pathol 1999; 26: 95-100.
10. Crowson AN, Magro CM. Subacute cutaneous lupus erythematosus arising in the setting of calcium channel blocker therapy. Human Pathol 1997; 28: 67-73.
11. Brooke R, Coulson IH, al-Dawoud A. Terbinafine-induced subacute cutaneous lupus erythematosus. [Letter] Br J Dermatol 1998; 139: 1132-1133.
12. Parodi A, Rivara G, Guarrera M. Possible naproxen-induced relapse of subacute cutaneous lupus erythematosus. JAMA 1992; 268: 51-52.
13. Sanchez-Guerrero J, Liang MH, Karlson EW, et al. Postmenopausal estrogen therapy and the risk of developing systemic lupus erythematosus. Ann Intern Med 1995; 122: 430-433.
14. Todd GR, McAteer EJ, Jack CM, et al. Pulmonary hypertension, systemic lupus erythematosus, and the contraceptive pill. Ann Rheum Dis 1985; 44: 266-267.
15. Garovich M, Agudelo C, Pisko E. Oral contraceptives and systemic lupus erythematosus. Arthritis Rheum 1980; 23: 1396-1398.
16. McConnachie PR, Zahalsky AC. Immunological consequences of exposure to pentachlorphenol. Arch Environ Health 1991; 46: 249-255.
17. McConnachie PR, Zahalsky AC. Immune alterations in humans exposed to the thermicide technical chlordane. Arch Environ Health 1992; 47: 295-301.
18. Thrasher JD, Madison R, Broughton A. Immunologic abnormalities in humans exposed to chlorpyrifos: preliminary observations. Arch Environ Health 1993; 48: 89-93.
19. Walsh BT, Reed M, Emerson J, et al. "Living is for everyone" community group: a large cluster of systemic lupus erythematosus individuals in a Mexican-American border town in Arizona. Arthritis Rheum 1993; 36: S145.
20. Kilburn KH, Warshaw RH. Prevalence of symptoms of systemic lupus erythematosus and of fluorescent antinuclear antibodies associated with chronic exposure to trichloroethylene and other chemicals in well water. Environ Res 1992; 57: 1-9.
21. Cooper GS, Dooley MA, Treadwell EL, et al. Hormonal, environmental and infectious risk factors for developing systemic lupus erythematosus. Arthritis Rheum 1998; 41: 1714-1724.
22. Khan MF, Kaphalia BS, Prabhakar BS, et al. Trichloroethene-induced autoimmune response in female MRL +/+ mice. Toxicol Appl Pharmacol 1995; 134: 155-160.
23. Reidenberg MM, Durant PJ, Harris RA, et al. Lupus erythematosus-like disease due to hydrazine. Am J Med 1983; 75: 365-370.
24. Mongey A-B, Hess EV. Drug and environmental effects on the induction of autoimmunity. J Lab Clin Med 1993; 122: 652-657.
25. Freni-Titulaer LWJ, Kelley DB, Grow AG, et al. Connective tissue disease in south eastern Georgia: a case control study of etiologic factors. Am J Epidemiol 1989; 130: 404-409.
26. Sanchez-Guerrero J, Karlson EW, Colditz GA, et al. Hair dye use and the risk of developing systemic lupus erythematosus: a cohort study. Arthritis Rheum 1996; 39: 657-662.
27. Petri M, Allbritton J. Hair product use in systemic lupus erythematosus: a case-control study. Arthritis Rheum 1992; 35: 625-629.
28. Bigazzi PE. Autoimmunity and heavy metals. Lupus 1994; 3: 449-453.
29. Federmann M, Morell B, Graetz G, et al. Hypersensitivity to molybdenum as a possible trigger of ANA-negative systemic lupus erythematosus. Ann Rheum Dis 1994; 53: 403-405.
30. Conrad K, Mehlhorn J, Lüthke K, et al. Systemic lupus erythematosus after heavy exposure to quartz dust in uranium mines: clinical and serological characteristics. Lupus 1996; 5: 62-69.
31. Sanchez-Roman J, Wichmann I, Salaberri J, et al. Multiple clinical and biological autoimmune manifestations in 50 workers after occupational exposure to silica. Ann Rheum Dis 1993; 52: 534-538.
32. Nagata C, Fujita S, Iwata H, et al. Systemic lupus erythematosus: a case-control epidemiologic study in Japan. Int J Dermatol 1995; 34: 333-337.
33. Benoni C, Nilsson Å, Nived O. Smoking and inflammatory bowel disease: comparison with systemic lupus erythematosus: a case-control study. Scand J Gastroenterol 1990; 25: 751-755.
34. Malinow MR, Bardana EJ Jr, Pirofsky B, et al. Systemic lupus erythematosus-like syndrome in monkeys fed alfalfa sprouts: role of a nonprotein amino acid. Science 1982; 216: 415-417.
35. Roberts JL, Hayashi JA. Exacerbation of SLE associated with alfalfa ingestion. [Letter] N Engl J Med 1983; 308: 1361.
36. D'Cruz D. Autoimmune diseases associated with drugs, chemicals and environmental factors. Toxicol Let 2000; 112-3: 421-432.
37. Gilkeson GS, Pippen AMM, Pisetsky DS. Induction of cross-reactive anti-dsDNA antibodies in preautoimmune NZB/NZW mice by immunization with bacterial DNA. J Clin Invest 1995; 95: 1398-1402.
38. Li EK, Cohen MG, Ho AK, Cheng AF. Salmonella bacteremia occurring concurrently with the first presentation of systemic lupus erythematosus. Br J Rheumatol 1993; 32: 66-67.
39. Hardgrave KL, Neas BR, Scofield RH, et al. Antibodies to vesicular stomatitis virus proteins in patients with systemic lupus erythematosus and in normal subjects. Arthritis Rheum 1993; 36: 962-970.
40. Sabbatini A, Bombardieri S, Mirgliorini P. Autoantibodies from patients with systemic lupus erythematosus bind a shared sequence of SmD and Epstein-Barr virus-encoded nuclear antigen EBNA I. Eur J Immunol 1993; 23: 1146-1152.
41. James JA, Kaufman KM, Farris AD, et al. An increased prevalence of Epstein-Barr virus infection in young patients suggests a possible etiology for systemic lupus erythematosus. J Clin Invest 1997; 100: 3019-3026.
42. Strom BL, Reidenberg MM, West S, et al. Shingles, allergies, family medical history, oral contraceptives, and other potential risk factors for systemic lupus erythematosus. Am J Epidemiol 1994; 140: 632-642.
43. Talal N, Flescher E, Dang H. Are endogenous retroviruses involved in human autoimmune disease? J Autoimmun 1992; 5: 61-66.
44. Perl A, Colombo E, Dai H, et al. Antibody reactivity to HRES-1 endogenous retroviral element identifies a subset of patients with systemic lupus erythematosus and overlap syndromes: correlation with antinuclear antibodies and HLA class II alleles. Arthritis Rheum 1995; 38: 1660-1671.
45. Rider JR, Ollier WER, Lock RJ, et al. Human cytomegalovirus infection and systemic lupus erythematosus. Clin Exp Rheumatol 1997; 15: 405-409.
46. Magro CM, Crowson AN, Dawood M, et al. Parvoviral infection of endothelial cells and its possible role in vasculitis and autoimmune diseases. J Rheumatol 2002; 29: 1227-1235.
47. Chassagne P, Mejjad O, Gourmelen O, et al. Exacerbation of systemic lupus erythematosus during human Parvovirus-B19 infection. Br. J Rheumatol 1993; 32: 158-159.
48. Enk CD, Sredni D, Blauvelt A, Katz SI. Induction of IL-10 gene expression in human keratinocytes by UVB exposure in vivo and in vitro. J Immunol 1995; 154: 4851-4856.
49. Kirnbauer R, Kock A, Neuner P, et al. Regulation of epidermal cell interleukin-6 production by UV light and corticosteroids. J Invest Dermatol 1991; 96: 484-489.
50. Kock A, Schwartz T, Kirnbauer R, et al. Human keratinocytes are a source for tumor necrosis alpha: evidence for synthesis and release upon stimulation with endotoxin or ultraviolet light. J Exp Med 1990; 172: 1609-1614.
51. Werth VP, Williams KJ, Fisher EA, et al. UVB irradiation alters cellular responses to cytokines: role in extracellular matrix gene expression. J Invest Dermatol 1997; 108: 290-294.
52. Werth VP, Zhang W. Wavelength-specific-synergy between ultraviolet radiation and interleukin-1α in the regulation of matrix-related genes: mechanistic role for tumor necrosis factor-α. J Invest Dermatol 1999; 113: 196-201.
53. Schwartz A, Bhardwaj R, Aragane Y, et al. Ultraviolet-B-induced apoptosis of keratinocytes: evidence for partial involvement of tumor necrosis factor-alpha in the formation of sunburn cells. J Invest Dermatol 1995; 104: 922-927.
54. Bazzoni F, Kruys V, Shakhov A, et al. Analysis of tumor necrosis factor promoter responses to ultraviolet light. J Clin Invest 1994; 93: 56-62.
55. Zhuang L, Wang B, Shinder GA, et al. TNF receptor p55 plays a pivotal role in murine keratinocyte apoptosis induced by ultraviolet B irradiation. J Immunol 1999; 162: 1440-1447.
56. Ayukawa K, Taniguchi S, Masumoto J, et al. La autoantigen is cleaved in the COOH terminus and loses the nuclear localization signal during apoptosis. J Biol Chem 2000; 275: 34465-34470.
57. Casciola-Rosen LA, Rosen L. Ultraviolet light-induced keratinocyte apoptosis. a potential mechanism for the induction of skin lesions and autoantibody production in LE. Lupus 1997; 6: 175-180.
58. Utz PJ, Hottelet M, Shur PH, et al. Proteins phosphorylated during stress-induced apoptosis are common targets for autoantibody production in patients with systemic lupus erythematosus. J Exp Med 1997; 185: 843-854.
59. Furukawa F, Kashihara-Sawami M, Lyons MB. Norris DA. Binding of antibodies to the extractable nuclear antigens SS-A/Ro and SS-B/La is induced on the surface of human keratinocytes by ultraviolet light (UVL): implications for the pathogenesis of photosensitive cutaneous lupus. J Invest Dermatol 1990; 94: 77-85.
60. Casciola-Rosen LA, Anhal G, Rosen A. Autoantigen targets in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med 1994; 179: 1317-1330.
61. LeFeber WP, Norris DA, Ryan SR, et al. Ultraviolet light induces binding of antibodies to selected nuclear antigens on cultured human keratinocytes. J Clin Invest 1984; 74: 1545-1551.
62. Bachmann M, Chang S, Slor H, et al. Shuttling of the autoantigen La between nucleus and cell surface after UV irradiation of human keratinocytes. Exp Cell Res 1990; 191: 171-180.
63. Golan TD, Elkon KB, Gharavi AE, et al. Enhanced membrane binding of autoantibodies to cultured keratinocytes of systemic lupus erythematosus patients after ultraviolet B/ultraviolet A irradiation. J Clin Invest 1992;90: 1067-1076.
64. Krutman J, Kock A, Schauer E, et al. Tumor necrosis factor beta and ultraviolet radiation are potent regulators of human keratinocyte ICAM-1 expression. J Invest Dermatol 1990; 95: 127-131.
65. Norris DA, Lyons MB, Middleton MH, et al. Ultraviolet radiation can either suppress or induce expression of intercellular adhesion molecule 1 (ICAM-1) on the surface of cultured human keratinocytes. J Invest Dermatol 1990;95: 132-138.
66. Boyd AW, Wawryk SO, Burns GF, et al. Intercellular adhesion molecule 1 (ICAM-1) has a central role in cell-cell contact dependent mediated immune mechanism. Pro Natl Acad Sci U S A 1988; 85: 3095-3099.
67. Makgoba MW, Sanders ME, Ginther Luce GE, et al. ICAM-1 a ligand for LFA-1-dependent adhesion by B, T and myeloid cells. Nature 1988; 331: 86-91.
68. Richardson B, Powers D, Hooper F, et al. Lymphocyte function-associated antigen 1 overexpression and T cell autoreactivity. Arthritis Rheum 1994; 37: 1363-1372.
69. Norris P, Poston RN, Thomas DS, et al. The expression of endothelial leukocyte adhesion molecule-1 (ELAM-1), intercellular adhesion molecule-1 (ICAM-1), and vascular cell adhesion molecule-1 (VCAM-1) in experimental cutaneous inflammation. a comparison of ultraviolet B erythema and delayed hypersensitivity. J Invest Dermatol 1991; 96: 763-770.
70. Swerlick RA, Lawley TJ. Role of microvascular endothelial cells in inflammation. J Invest Dermatol 1993; 100: 111S-115S.
71. Bennion SD, Norris DA. Ultraviolet light modulation of autoantigens, epidermal cytokines and adhesion molecules as contributing factors of the pathogenesis of cutaneous LE. Lupus 1997; 6: 181-192.
72. IC) that regulate cell proliferation. Adv Biosci 1993; 89: 31-41.
73. Falus A, Meretey K. Histamine: an early messenger in inflammatory and immune reactions. Immunol Today 1992; 13: 154-156.
74. Rocklin RE, Haberek-Davidson A. Histamine activates suppressor cells in vitro using a coculture technique. J Clin Immunol 1981; 1: 73-79.
75. Wagner K, Neumayer HH. Influence of the calcium antagonist diltiazem on delayed graft function in cadaveric kidney transplantation: results of a 6-month follow-up. Transplant Proc 1987; 19: 1353-1357.
76. Derenne F, Vanhaeverbeek M, Brohee D. Nifedipine-induced hyporeactivity in delayed hypersensitivity skin tests. Int J Immunopharmacol 1987; 9: 741-744.
77. Magro CM, Crowson AN. Drug-induced immune dysregulation as a cause of atypical cutaneous lymphoid hyperplasia: a hypothesis. Hum Pathol 1996; 27: 125-132.
78. Weir MR, Peppler R, Gomolka D, et al. Additive inhibitory effect of cyclosporin and verapamil may occur through different mechanisms that may be dependent or independent of the slow calcium channel. Transplant Proc 1989; 21: 866-870.
79. McMillen MA, Lewis T, Jaffe BM, et al. Verapamil inhibition of lymphocyte proliferation and function in vivo. J Surg Res 1985; 39: 76-80.
80. Brandes LJ, LaBella FS. Histamine and calcium are independently regulated intracellular mediators of lymphocyte mitogenesis. Biochem Biophys Res Commun 1992; 182: 786-793.
81. Miyagawa S, Okada N, Inagaki Y, et al. SSA/Ro antigen expression in simian virus-40-transformed human keratinocytes. J Invest Dermatol 1988; 90: 342-345.
82. McCauliffe DP, Sontheimer RD. Molecular characterization of the Ro SS-A autoantigens. J Invest Dermatol 1993; 100: 73S-79S.
83. Wang D, Chan EKL. 17-α-estradiol increases expression of 52-kDa and 60-kDa SS-A/Ro autoantigens in human keratinocytes and breast cancer cell line MCF-7. J Invest Dermatol 1996; 107: 610-614.
84. Sakabe K, Yoshida T, Furuya H, et al. Estrogenic xenobiotics increase expression of SS-A/Ro autoantigens in cultured human epidermal cells. Acta Derm Venereol (Stockh) 1998; 78: 420-423.
85. Furukawa F, Lyons MB, Lee LA, Coulter SN, Norris DA. Estradiol enhances binding to cultured human keratinocytes of antibodies specific for SS-A/Ro and SS-B/La. Another possible mechanism for estradiol influence of lupus erythematosus. J Immunol 1988; 141: 1480-1488.
86. Jones SK. The effects of hormonal and other stimuli on cell-surface Ro/SSA antigen expression by human keratinocytes in vitro: their possible role in the induction of cutaneous lupus lesions. Br J Dermatol 1992; 126: 554-560.
87. Toyoda M, Galfayan K, Galera OA, et al. Cytomegalovirus infection induces anti-endothelial cell antibodies in cardiac and renal allograft recipients. Transpl Immunol 1997; 5: 104-111.
88. Toyoda M, Petrosian A, Jordan SC. Immunological characterization of anti-endothelial cell antibodies induced by cytomegalovirus infection. Transplantation 1999; 68: 1311-1318.
89. Landini MP, Severi B, Badiali L, et al. Structural components of human cytomegalovirus: in situ localization of the major glycoprotein. Intervirology 1987; 27: 154-160.
90. Severi B, Landini MP, Govoni E. Human cytomegalovirus morphogenesis: an ultrastructural study of the late cytoplasmic phases. Arch Virol 1988; 98: 51-64.
91. Beck S, Bartell BC. Human cytomegalovirus encodes a glycoprotein homologous to MHC class-I antigens. Nature 1988; 331: 269-272.
92. Fujinami RS, Nelson JA, Walker L, et al. Sequence homology and Immunologic cross-reactivity of human cytomegalovirus with HLA-DR beta-chain: a means for graft rejection and immunosuppression. J Virol 1988; 62: 100-105.
93. Neote K, Digregorio D, Mak JY, et al. Molecular cloning, functional expression, and signaling characteristics of a C-C chemokine receptor. Cell 1993; 72: 415-425.
94. Gharavi AE, Pierangeli SS, Espinola RG, et al. Antiphospholipid antibodies induced in mice by immunization with a cytomegalovirus-derived peptide cause thrombosis and activation of endothelial cells in vivo. Arthritis Rheum 2002; 46: 545-552.
95. Sol N, Junter JL, Vassias I. Possible interactions between the NS-1 protein and tumor necrosis factor alpha pathways in erythroid cell apoptosis induced by human parvovirus B19. J Virol 1999; 73: 8762-8770.
96. Werth VP, Zhang W, Dortzbach K, et al. Association of a promoter polymorphism of tumor necrosis factor-alpha with subacute cutaneous lupus erythematosus and distinct photoregulation of transcription. J Invest Dermat 2000; 115: 726-730.